Abdullah, Wahida B.
HRN: 21-29-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
CO-AMOXICLAV 625MG (TAB)
05/07/2022
05/12/2022
IV
625
BID
S/PRIMARY LOW TRANSVERSE CAESAREAN SECTION
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes